Long-term adherence to a 5 day antibiotic course guideline for treatment of intensive care unit (ICU)-associated Gram-negative infections.

OBJECTIVES To determine long-term adherence to a 5 day antibiotic course guideline for treating intensive care unit (ICU)-acquired Gram-negative bacteria (GNB) infections. METHODS Descriptive analysis of patient-level data on all GNB-active antibiotics prescribed from day 3 and all GNB identified in clinical samples in 5350 patients admitted to a 30 bed general ICU between 2002 and 2009. RESULTS Four thousand five hundred and eleven of 5350 (84%) patients were treated with one or more antibiotics active against GNB commenced from day 3. Gentamicin was the most frequently prescribed antibiotic (92.2 days of therapy/1000 patient-days). Only 6% of courses spanned >6 days of therapy and 89% of antibiotic therapy days were with a single antibiotic active against GNB. There was no significant difference between gentamicin and meropenem in the number of first courses in which a resistant GNB was identified in blood cultures [11/1177 (0.9%) versus 5/351 (1.4%); P = 0.43] or respiratory tract specimens [59/951 (6.2%) versus 17/246 (6.9%); P = 0.68] at the time of starting therapy. CONCLUSIONS This study demonstrates long-term adherence to a 5 day course antibiotic guideline for treatment of ICU-associated GNB infections. This guideline is a potential antibiotic-sparing alternative to currently recommended dual empirical courses extending to ≥7 days.

[1]  B. Cooper,et al.  Clustering of Antimicrobial Resistance Outbreaks Across Bacterial Species in the Intensive Care Unit , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[3]  R. Sawyer,et al.  Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. , 2012, The Lancet. Infectious diseases.

[4]  Frédérique Jacobs,et al.  Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?* , 2012, Critical care medicine.

[5]  Dirk Vogelaers,et al.  The rising problem of antimicrobial resistance in the intensive care unit , 2011, Annals of intensive care.

[6]  N. Daneman,et al.  Impact of antimicrobial stewardship in critical care: a systematic review. , 2011, The Journal of antimicrobial chemotherapy.

[7]  J. Ramirez,et al.  Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. , 2011, The Lancet. Infectious diseases.

[8]  F. Jacobs.  Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. , 2011, Critical care medicine.

[9]  M. Pfaller.  Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs , 2010 .

[10]  M. Singer,et al.  Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC). , 2010, The Journal of antimicrobial chemotherapy.

[11]  Anand Kumar,et al.  A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study , 2010, Critical care medicine.

[12]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[14]  A. Gascoigne,et al.  Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy , 2008, The Journal of antimicrobial chemotherapy.

[15]  D. Cook,et al.  Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia* , 2008, Critical care medicine.

[16]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[17]  J. Ariza,et al.  Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality. , 2008, The Journal of hospital infection.

[18]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[19]  J. Rello,et al.  Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy* , 2007, Critical care medicine.

[20]  M. Niederman,et al.  Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  S. Markantonis,et al.  Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia. , 2005, Chest.

[22]  G. Tillotson,et al.  The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia. , 2005, Chest.

[23]  M. Singer,et al.  Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy. , 2004, The Journal of antimicrobial chemotherapy.

[24]  G. Bertolini,et al.  Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study. , 2004, The Journal of antimicrobial chemotherapy.

[25]  Michel Wolff,et al.  Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. , 2003, JAMA.

[26]  M. Singer,et al.  Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. , 2003, The Journal of antimicrobial chemotherapy.

[27]  M. Rybak,et al.  Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  J. Rello,et al.  Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. , 2003, Chest.

[29]  R. Zaragoza,et al.  The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[31]  S. Eykyn,et al.  A 25-year study of nosocomial bacteremia in an adult intensive care unit. , 1999, Critical care medicine.

[32]  G Sherman,et al.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.

[33]  F. V. van Tiel,et al.  Indications for antibiotic use in ICU patients: a one-year prospective surveillance. , 1997, The Journal of antimicrobial chemotherapy.

[34]  M. Barclay,et al.  What is the Evidence for Once-Daily Aminoglycoside Therapy? , 1994, Clinical pharmacokinetics.

[35]  R. Simes,et al.  An improved Bonferroni procedure for multiple tests of significance , 1986 .

[36]  N. Rollins,et al.  Nosocomial pneumonia: de-escalation is what matters , 2011 .

[37]  M. Mathru.  Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock , 2010 .

[38]  J. Carlet,et al.  Defining, treating and preventing hospital acquired pneumonia: European perspective , 2008, Intensive Care Medicine.

[39]  S. Walther,et al.  Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control , 2008, Intensive Care Medicine.

[40]  L. Leibovici,et al.  Septic shock in bacteremic patients: risk factors, features and prognosis. , 1997, Scandinavian journal of infectious diseases.

[41]  D. Persing.  A guide to sensitivity testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. , 1991, The Journal of antimicrobial chemotherapy.